General MedicationsORALGeneric
TERRAMYCIN
OXYTETRACYCLINE HYDROCHLORIDE
Standard Dose
EQ 125MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary
Approval overview TERRAMYCIN is listed in Drugs@FDA under application 050286 (NDA).
Review priority: UNKNOWN Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 125MG BASE Sponsor PFIZER Submission history Latest submission status date: 1964-09-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview TERRAMYCIN is listed in Drugs@FDA under application 050286 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 125MG BASE Sponsor PFIZER Submission history Latest submission status date: 1964-09-08 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.